A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.

Completed · Phase 2

Conditions studied: Non-Small-Cell Lung Carcinoma, Adenocarcinoma

In brief

To determine if the addition of AG-013736 to chemotherapy is beneficial in patients with advanced lung cancer who have not been previously treated.

Key facts

Study ID

NCT00600821

Run by

Pfizer

People needed

118

Starts

2008-04-01

Expected to finish

2012-10-01

Last updated by the study team

2013-11-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Advanced non squamous cell, lung cancer
• No prior treatment for lung cancer except prior adjuvant therapy if last dose was >12 months prior to enrollment

You may not qualify if…

• Prior therapy for advanced lung cancer
• The need for blood-thinners
• Coughing up blood

Where it is running

• Pfizer Investigational Site — Baton Rouge, Louisiana, United States
• Pfizer Investigational Site — Pittsfield, Massachusetts, United States
• Pfizer Investigational Site — Columbus, Mississippi, United States
• Pfizer Investigational Site — Corinth, Mississippi, United States
• Pfizer Investigational Site — New Albany, Mississippi, United States
• Pfizer Investigational Site — Oxford, Mississippi, United States
• Pfizer Investigational Site — Southaven, Mississippi, United States
• Pfizer Investigational Site — Tupelo, Mississippi, United States
• Pfizer Investigational Site — Lincoln, Nebraska, United States
• Pfizer Investigational Site — Cleveland, Ohio, United States
• Pfizer Investigational Site — Bartlett, Tennessee, United States
• Pfizer Investigational Site — Germantown, Tennessee, United States
• Pfizer Investigational Site — Memphis, Tennessee, United States
• Pfizer Investigational Site — Memphis, Tennessee, United States
• Pfizer Investigational Site — Dallas, Texas, United States
• Pfizer Investigational Site — Dallas, Texas, United States
• Pfizer Investigational Site — Dallas, Texas, United States
• Pfizer Investigational Site — Dallas, Texas, United States
• Pfizer Investigational Site — Lubbock, Texas, United States
• Pfizer Investigational Site — San Antonio, Texas, United States
• Pfizer Investigational Site — San Antonio, Texas, United States
• Pfizer Investigational Site — Wenatchee, Washington, United States
• Pfizer Investigational Site — Prague, Czechia
• Pfizer Investigational Site — Tábor, Czechia
• Pfizer Investigational Site — Ústí nad Labem, Czechia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.